Area of research
Pathology and Forensic Medicine · Immunology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, T-cell and B-cell Immunology, and Immune Cell Function and Interaction.
Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach
Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Delay from treatment start to full effect of immunotherapies for multiple sclerosis
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
Incidence and prevalence of NMOSD in Australia and New Zealand
Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation?
Defining secondary progressive multiple sclerosis
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
Contribution of different relapse phenotypes to disability in multiple sclerosis
Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis
Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4+CD25+ T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients